CELIUS , Elisabeth G.

During the COVID-19 pandemic, people with multiple sclerosis (MS) and their healthcare providers have faced unique challenges related to the interaction between SARS-CoV-2, underlying neurological disease and the use of disease- modifying treatments (DMTs). Key concerns arose, primarily related to the possibility that SARS-CoV-2 infection could...